BDBM62546 2-[4-(1-Propyl-1H-benzoimidazol-2-yl)-piperazin-1-yl]-N-thiophen-2-ylmethyl-acetamide::2-[4-(1-propyl-2-benzimidazolyl)-1-piperazinyl]-N-(thiophen-2-ylmethyl)acetamide::2-[4-(1-propylbenzimidazol-2-yl)piperazin-1-yl]-N-(thiophen-2-ylmethyl)acetamide::2-[4-(1-propylbenzimidazol-2-yl)piperazin-1-yl]-N-(thiophen-2-ylmethyl)ethanamide::2-[4-(1-propylbenzimidazol-2-yl)piperazino]-N-(2-thenyl)acetamide::MLS000027288::SMR000006440::cid_649881

SMILES COCn1nc2cc(N3CCCOc4cc(C(=O)N5CCCCC5)cnc43)ccn2c1=O

InChI Key InChIKey=XVOYEJOEWNJFFY-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 62546   

Target15-hydroxyprostaglandin dehydrogenase [NAD(+)](Human)
Kyorin Pharmaceutical Co.

US Patent
LigandChemical structure of BindingDB Monomer ID 62546BDBM62546(US12577217, Example 1-52)
Affinity DataIC50: 10nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 &...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/27/2026
Entry Details
US Patent